Cargando…

Thyroid disease is a favorable prognostic factor in achieving sustained virologic response in chronic hepatitis C undergoing combination therapy: A nested case control study

BACKGROUND: Interferon-α in combination with ribavirin is the current gold standard for treatment of chronic hepatitis C. It is unknown if the development of autoimmune thyroid disease (TD) during treatment confers an improved chance of achieving sustained virologic response. The aim of this study i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tran, Huy A, Jones, Tracey L, Gibson, Robert, Reeves, Glenn EM
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123561/ https://www.ncbi.nlm.nih.gov/pubmed/21605462 http://dx.doi.org/10.1186/1472-6823-11-10

Ejemplares similares

The natural history of interferon-α induced thyroiditis in chronic hepatitis c patients: a long term study
por: Tran, Huy A, et al.
Publicado: (2011)

The influence of hepatitis C infection and interferon-α therapy on thyrotropin blocking and stimulating autoantibodies in Graves' ophthalmopathy: a case report
por: Tran, Huy A, et al.
Publicado: (2009)

The Reduced Predictive Value of Interleukin 28b Gene Polymorphisms in a Cohort of Patients With Thyroiditis Developed During Antiviral Therapy for Chronic Hepatitis C: A Preliminary Study
por: Tran, Huy A, et al.
Publicado: (2012)

Durability of antiviral therapy for chronic hepatitis C after achieving sustained virological response
por: Heo, Jeong
Publicado: (2011)

The Spectrum of Autoimmune Thyroid Disease in the Short to Medium Term Following Interferon-α Therapy for Chronic Hepatitis C
por: Tran, Huy A., et al.
Publicado: (2009)

Direct-acting antivirals trigger a favorable, sustained virological response in patients with chronic hepatitis C infections and hepatocellular carcinoma
por: Sohn, Won
Publicado: (2021)

Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits
por: Smith-Palmer, Jayne, et al.
Publicado: (2015)

Necessity for surveillance for hepatocellualr carcinoma in older patients with chronic hepatitis C who achieved sustained virological response
por: Ishido, Shun, et al.
Publicado: (2023)

Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon‐Free Therapy
por: Mandorfer, Mattias, et al.
Publicado: (2019)

Achieving the Sustained Virologic Response With a Short-Course Treatment of Sofosbuvir/Velpatasvir
por: Abi-Saleh, Simon P, et al.
Publicado: (2023)

Durability of Sustained Virologic Response in Chronic Hepatitis C
por: Uyanikoglu, Ahmet, et al.
Publicado: (2013)

2222. Impact of Sustained Virologic Response Achieved Through Newer Direct Acting Antivirals in Hepatitis C Infection on Diabetes Mellitus
por: Mada, Pradeep Kumar, et al.
Publicado: (2018)

Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study
por: Liu, Chen-Hua, et al.
Publicado: (2022)

Achieving sustained virologic response after interferon‐free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis
por: Meissner, E. G., et al.
Publicado: (2016)

Role of PNPLA3 in the Assessment and Monitoring of Hepatic Steatosis and Fibrosis in Patients with Chronic Hepatitis C Infection Who Achieved a Sustained Virologic Response
por: Gavril, Oana Irina, et al.
Publicado: (2021)

Predictors of early and sustained virological response of viral hepatitis C
por: Ghenea, Alice Elena, et al.
Publicado: (2020)

Obesity and recurrence‐free survival in patients with hepatocellular carcinoma after achieving sustained virological response to interferon therapy for chronic hepatitis C
por: Shinkawa, Hiroji, et al.
Publicado: (2018)

Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance
por: Griffith, Anna S, et al.
Publicado: (2018)

Early treatment regimens achieve sustained virologic remission in infant macaques infected with SIV at birth
por: Wang, Xiaolei, et al.
Publicado: (2022)

The spectrum of thyroid dysfunction in an Australian hepatitis C population treated with combination Interferon-α2β and Ribavirin
por: Tran, Huy A, et al.
Publicado: (2005)

Intravenous Drug Users Can Achieve a High Sustained Virological Response Rate: experience From Croatian Reference Center for Viral Hepatitis
por: Kurelac, Ivan, et al.
Publicado: (2011)

Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis
por: Simmons, Bryony, et al.
Publicado: (2016)

Development of Hepatocellular Carcinoma in a Patient with Chronic Hepatitis C 21 Years after Achieving a Sustained Virological Response to Interferon Therapy
por: Hara, Tasuku, et al.
Publicado: (2020)

Detection of Occult Hepatitis C Virus Infection in Egyptian Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents
por: Mashaal, Ahmed R, et al.
Publicado: (2022)

Favorable Outcomes of Chinese HCV-Related Cirrhotic Patients with Sustained Virological Response after Pegylated Interferon Plus Ribavirin Treatment
por: Zhang, Geng-lin, et al.
Publicado: (2017)

Prognostic Factors for Overall Survival in Patients with HCV-Related HCC Undergoing Molecular Targeted Therapies: Beyond a Sustained Virological Response
por: Minami, Yasunori, et al.
Publicado: (2022)

Improved liver function in patients with cirrhosis due to chronic hepatitis C virus who achieve sustained virologic response is not accompanied by increased liver volume
por: Wake, Taijiro, et al.
Publicado: (2020)

Follow-Up of Patients Who Achieved Sustained Virologic Response after Interferon-Free Treatment against Hepatitis C Virus: Focus on Older Patients
por: Nirei, Kazushige, et al.
Publicado: (2021)

A novel formula used for predicting hepatocellular carcinoma after the achievement of sustained virologic response by direct-acting antivirals in patients with chronic hepatitis C
por: Yoshida, Yuji, et al.
Publicado: (2023)

Hepatitis C: Problems to extinction and residual hepatic and extrahepatic lesions after sustained virological response
por: Cuesta-Sancho, Sara, et al.
Publicado: (2022)

Impact of sustained virologic response on chronic kidney disease progression in hepatitis C
por: Aby, Elizabeth S, et al.
Publicado: (2017)

Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response
por: Sasaki, Reina, et al.
Publicado: (2018)

Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response
por: Welsch, Christoph, et al.
Publicado: (2017)

Management of betablocked patients after sustained virological response in hepatitis C cirrhosis
por: Abadía, Marta, et al.
Publicado: (2019)

Positive predictive value of sustained virologic response 4 weeks posttreatment for achieving sustained virologic response 12 weeks posttreatment in patients receiving glecaprevir/pibrentasvir in Phase 2 and 3 clinical trials
por: Gane, Edward, et al.
Publicado: (2021)

Incubation determines favorable microbial communities in Chinese alligator nests
por: Yu, Qin-Zhang, et al.
Publicado: (2022)

Exacerbation of hepatitis C induced subclinical hypoadrenalism by Interferon-alpha2beta: A case report
por: Tran, Huy A, et al.
Publicado: (2008)

Weight loss, leukopenia and thrombocytopenia associated with sustained virologic response to Hepatitis C treatment
por: Suwantarat, Nuntra, et al.
Publicado: (2010)

Predictors of sustained virologic response in hepatitis C genotype 4: beyond the usual suspects
por: Abdo, Ayman A., et al.
Publicado: (2009)

Predictors of sustained virological response in patients with hepatitis C virus genotype 3 infection
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_53ghfjsjm4qfe2ht8fcm4it9gu